Medicamen Biotech consolidated net profit rises 44.58% in the December 2024 quarter
Sales decline 2.92% to Rs 45.14 crore
Net profit of Medicamen Biotech rose 44.58% to Rs 3.47 crore in the quarter ended December 2024 as against Rs 2.40 crore during the previous quarter ended December 2023. Sales declined 2.92% to Rs 45.14 crore in the quarter ended December 2024 as against Rs 46.50 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var.Sales45.1446.50 -3 OPM %14.8610.52 -PBDT6.095.08 20 PBT3.883.27 19 NP3.472.40 45Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Feb 11 2025 | 5:46 PM IST